l.krastev

TL2 · Łódź

Contributes reviews on supplier material. Based in Łódź.

Joined 10 January 2025 · last posted 6d

79 posts, newest first. Showing up to 150.

What steady state means for the decision to escalate Replied, post #33 · Practice › Dosing & titration · 22 Jul 2026 · 8 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
CJC-1295 with and without DAC: what the modification does Replied, post #114 · Compounds › Secretagogues & GH axis · 17 Jul 2026 · 31 likes Post #112 and I disagree about the size of the effect, not about the direction. On analysis: these are short peptides and generally straightforward chromatographically,…
Forced degradation studies: designing one that is informative Replied, post #99 · Analytics › Method validation · 16 Jul 2026 · 0 likes I have no financial interest in anything named in this thread and I want to say so before I comment on forced degradation studies, because it is the sort of subject…
Follow-up: Sleep quality changes during weight loss Replied, post #63 · Wellbeing › Sleep · 7 Jul 2026 · 0 likes Post #61 is right about the mechanism and I think understates the practical bit. Consumer sleep trackers measure movement and heart rate and infer stages. The inference…
Revisiting: What pooling buys you and what it destroys Replied, post #78 · Evidence › Meta-analyses · 4 Jul 2026 · 0 likes The documentation on pooling buys is better than this thread and I say that as someone who has posted in the thread.
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #76 · Safety › Contraindications · 17 Jun 2026 · 3 likes This follows post #75 rather than contradicting it. Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one…
Why this subcategory is stricter about sourcing than most Replied, post #43 · Compounds › Secretagogues & GH axis · 15 Jun 2026 · 14 likes Adding the measurement that post #42 says would settle it. On analysis: these are short peptides and generally straightforward chromatographically, which means a poor…
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #14 · Start Here › How to Ask · 21 May 2026 · 0 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #53 · Compounds › Repair & healing peptides · 13 May 2026 · 0 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #42 · Practice › Interactions · 12 May 2026 · 26 likes The arithmetic in post #39 is right; the assumption feeding it is the part to check. What I want from this widely repeated interaction claim thread is the list of…
Personal import allowances, compared — a second dataset Replied, post #120 · Access › International · 10 May 2026 · 4 likes Personal import allowances was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Gastro-oesophageal reflux: improving or worsening? Replied, post #40 · Clinical › Comorbidities · 28 Apr 2026 · 0 likes Where two conditions pull in opposite directions, that is a clinical judgement rather than a lookup, and it is the kind of question a forum answers worst. Take the…
Prescription requirements and telehealth models — a second dataset Replied, post #14 · Sourcing › Regulatory · 28 Apr 2026 · 9 likes Narrowing post #11, because the general version has more than one answer. I read the earlier replies on Prescription requirements and telehealth models twice before…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #122 · Analytics › Mass spectrometry · 28 Apr 2026 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Reused chromatograms across lots: how to spot it — what changed since Replied, post #34 · Analytics › COA interpretation · 26 Apr 2026 · 0 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #55 · Data & Tools › Datasets · 23 Apr 2026 · 2 likes Post #53 describes the usual case. This is about the unusual one. Where a value is derived rather than measured, mark it. Derived columns get treated as observations…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #55 · Practice › Administration · 22 Apr 2026 · 0 likes Injecting slowly is worth doing for volume rather than for chemistry. Larger volumes delivered quickly are the ones people report as uncomfortable. This is the version…
About the Preprints category Replied, post #7 · Evidence › Preprints · 21 Apr 2026 · 17 likes Worth separating two things that post #3 runs together. Conference abstracts are weaker than preprints and get quoted with equal confidence. An abstract is a few…
Spike-and-recover accuracy for a peptide assay Replied, post #113 · Analytics › Method validation · 10 Apr 2026 · 16 likes Picking up post #112: that is the part I would want checked first. Where I would push back on the spike-and-recover accuracy consensus is the confidence, not the…
Revisiting: Absolute versus relative contraindications Replied, post #63 · Safety › Contraindications · 10 Apr 2026 · 0 likes The confident answers on Absolute versus relative contraindications and the well-sourced answers are not the same answers, which is the most useful thing I have learned…
Foaming during reconstitution and whether it matters — the long version Replied, post #91 · Practice › Reconstitution · 8 Apr 2026 · 20 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. I am…
Why the timeline is on the right and not the left — what changed since Replied, post #9 · Meta › Site feedback · 21 Mar 2026 · 32 likes Coming back to post #5, because the follow-up matters more than the original answer. Two people in this thread mean different things by timeline and are disagreeing…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #2 · Evidence › Journal club · 15 Feb 2026 · 5 likes That is the distinction I keep failing to hold on to. Written down now.
Realistic expectations for strength while losing weight quickly Replied, post #61 · Nutrition & Training › Resistance training · 10 Feb 2026 · 14 likes Post #58 is right about the mechanism and I think understates the practical bit. Nobody has said the unglamorous part of realistic expectations for strength yet, so:…
Trifluoroacetate content and its consequences Replied, post #65 · Analytics › Impurities & related substances · 2 Feb 2026 · 27 likes Oxidation at methionine or tryptophan adds sixteen per oxygen and typically elutes earlier. In aged material it is the modification that grows. A qualification I should…
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #54 · Documentation › Doc review · 28 Jan 2026 · 16 likes Where I part company with post #51, and it is a narrow parting. Ask what the page would look like if it were wrong. A document with no stated failure conditions is hard…
[2026 update] Evidence quality in the secretagogue literature: an honest assessment Replied, post #14 · Compounds › Secretagogues & GH axis · 23 Jan 2026 · 32 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
The decimal-point error, and the habit that catches it Replied, post #122 · Practice › Reconstitution · 18 Dec 2025 · 14 likes The most useful thing anyone has posted about decimal-point error in this category was a table of what had been measured and by whom. That is what I would want again.
Coming back to: Payment mechanics and the recovery options that do not exist Replied, post #3 · Sourcing › Payments · 10 Dec 2025 · 3 likes Narrowing the opening post, because the general version has more than one answer. No payment facilitation: this site does not handle payments and does not connect…
About the Statistics category Replied, post #7 · Research Methods › Statistics · 30 Nov 2025 · 6 likes Regression to the mean: if you select people with extreme values (very high or very low), their next measurement is often less extreme just by chance. This can look…
Batch date after test date, and other internal inconsistencies Replied, post #21 · Analytics › COA interpretation · 27 Nov 2025 · 0 likes What I would want before treating batch date as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #35 · Compounds › Semaglutide · 17 Nov 2025 · 0 likes This follows post #34 rather than contradicting it. On semaglutide solutions the community has more anecdote than the confidence in this thread implies, and I include…
Pen dose counters: what a click does and does not guarantee Replied, post #51 · Devices › Pens & autoinjectors · 16 Nov 2025 · 5 likes Adding thanks rather than a view. I do not have a view worth the space.
[2026 update] Long-time reader, first-time poster Replied, post #25 · Lounge › Introductions · 14 Nov 2025 · 0 likes Small methodological point on Long-time reader: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #60 · Compounds › Tirzepatide · 13 Nov 2025 · 30 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
Airline travel with a temperature-sensitive injectable Replied, post #10 · Devices › Cold chain · 25 Oct 2025 · 15 likes Post #6 describes the usual case. This is about the unusual one. A methods point on airline travel rather than a substantive one: if the comparison is not like for…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #35 · Start Here › Welcome · 15 Oct 2025 · 0 likes If you are not sure which subcategory a question belongs in, post it in the closest one. A moderator will move it, the move is logged, and nothing bad happens to you. I…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #27 · Compounds › Semaglutide · 15 Oct 2025 · 22 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #31 · Wellbeing › Mental health · 27 Sep 2025 · 0 likes Following this. I have the same question and no better information than the first post.
Tracking that stops updating and then resumes — the long version Replied, post #18 · Sourcing › Logistics · 24 Sep 2025 · 11 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #80 · Evidence › Study critique · 15 Sep 2025 · 0 likes Surrogate endpoints are not automatically bad and their validity is compound-specific and population-specific. The question is whether this surrogate has been validated…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #19 · Data & Tools › Datasets · 9 Sep 2025 · 13 likes Bias toward positive outcomes: datasets collected by members are biased toward people who found the compounds useful. People who did not respond do not return. People…
Are there stupid questions here? A staff answer, at length Replied, post #84 · Start Here › Welcome · 18 Aug 2025 · 0 likes If you are not sure which subcategory a question belongs in, post it in the closest one. A moderator will move it, the move is logged, and nothing bad happens to you.…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #52 · Evidence › Journal club · 17 Aug 2025 · 0 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.
Are there stupid questions here? A staff answer, at length Replied, post #67 · Start Here › Welcome · 13 Aug 2025 · 5 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
Thyroid function tests during substantial weight change Replied, post #26 · Clinical › Bloodwork · 9 Aug 2025 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #91 · Compounds › Repair & healing peptides · 4 Aug 2025 · 4 likes Post #90 answers the question as asked. The question underneath it is different. Where I would push back on the TB-500 and thymosin beta-4 consensus is the confidence,…
Canadian access and provincial variation — one year on Replied, post #36 · Regional › North America · 27 Jul 2025 · 26 likes Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream…
Discussing something you have already been doing — the long version Replied, post #10 · Clinical › Prescriber conversations · 9 Jul 2025 · 0 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. I would treat that as a working assumption and revisit…
Which panel is worth repeating and which is worth ignoring Replied, post #52 · Clinical › Bloodwork · 3 Jul 2025 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #60 · Compounds › Repair & healing peptides · 20 Jun 2025 · 11 likes Taking post #58 at face value and following it one step further. The distinction between "no evidence it works" and "evidence it does not work": we have the first for…
Coming back to: When "no data" is the complete and final answer Replied, post #18 · Compounds › Other compounds · 19 Jun 2025 · 0 likes Helpful, and short, which on this subject is harder than long.
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #48 · Evidence › Trials · 8 Jun 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
Pre-registering a personal experiment, seriously Replied, post #7 · Research Methods › N-of-1 designs · 25 May 2025 · 7 likes Nothing in a personal experiment is medical advice to anyone including yourself, and several people here have found that a prescriber will happily discuss a…
Pregnancy as an absolute contraindication Replied, post #21 · Safety › Contraindications · 17 May 2025 · 22 likes Pregnancy came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Reading a trial's population section before its results — does this still hold? Replied, post #113 · Evidence › Trials · 17 May 2025 · 4 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #109 · Compounds › Cagrilintide & amylin analogues · 4 May 2025 · 20 likes Post #106 answers the question as asked. The question underneath it is different. Where the amylin analogue mechanism reasoning breaks down for me is the step from the…
Why the timeline is on the right and not the left Replied, post #13 · Meta › Site feedback · 1 May 2025 · 24 likes Post #9 and I disagree about the size of the effect, not about the direction. Seconding that. I would put solved-only in front of the sort control rather than behind…
Coverage for the indication versus for the drug Replied, post #47 · Access › Insurance & coverage · 30 Apr 2025 · 12 likes Coverage for the device and for the compound can be decided separately, which surprises people at the pharmacy counter. If it helps: the failure mode here is usually…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #140 · Sourcing › Regulatory · 29 Apr 2025 · 18 likes Nobody has said the unglamorous part of Research-use-only labelling yet, so: most of the variation is explained by things that are boring to write about and easy to…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #131 · Sourcing › Vendor reports · 18 Mar 2025 · 1 like I read post #129 twice before replying, because I had assumed the opposite. Do not adjust a reported figure. Post what the laboratory said and put your interpretation…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #117 · Compounds › Other compounds · 17 Mar 2025 · 12 likes On post #116 — agreed on the reasoning, with one qualification. The useful distinction on Research-use-only status is between what was measured and what was inferred…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #38 · Sourcing › Regulatory · 1 Mar 2025 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #103 · Data & Tools › Calculators · 24 Feb 2025 · 0 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
What we do not know about retatrutide, listed explicitly Replied, post #94 · Compounds › Retatrutide · 13 Feb 2025 · 0 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #33 · Evidence › Meta-analyses · 13 Feb 2025 · 1 like When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
Follow-up: What other technical communities get right that we do not Replied, post #14 · Lounge › Off topic · 9 Feb 2025 · 3 likes Something I have wondered without ever asking: is there a good reason the vocabulary in this field is so inconsistent between suppliers? Half the disagreements here…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #115 · Evidence › Journal club · 4 Feb 2025 · 0 likes Second this, and I would have said it less carefully.
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #76 · Data & Tools › Calculators · 3 Feb 2025 · 28 likes This is the first time the answer has come with its own limits attached. Appreciated.
Checking someone else's arithmetic: a worked example thread Replied, post #15 · Practice › Reconstitution · 18 Jan 2025 · 2 likes Adding the measurement that post #14 says would settle it. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #2 · Analytics › COA interpretation · 13 Jan 2025 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Recovery when intake is low: what to cut first Replied, post #44 · Nutrition & Training › Resistance training · 12 Jan 2025 · 1 like Where somebody is losing strength rapidly, the first questions are intake, sleep and total training volume, in that order. This is the sort of thing that ought to be…
EMA product information as a primary source — does this still hold? Replied, post #135 · Regional › European Union · 18 Nov 2024 · 31 likes Coming back to post #133, because the follow-up matters more than the original answer. EMA product information is well covered in the tag pages, and the older…
Blind submission and why it changes minds Replied, post #85 · Sourcing › Independent verification · 11 Oct 2024 · 1 like This is the sort of exchange that makes the archive worth searching.
Second pass at: Hoarding and why it makes a shortage worse Replied, post #70 · Access › Shortages · 11 Oct 2024 · 11 likes Building on post #69 rather than restating it. Anyone reporting availability should say the region and the date, because both determine whether the report is usable. If…
Journal club: SURMOUNT-1, read without the press release Started this topic · Evidence › Journal club · 5 Oct 2024 · 0 likes Journal club: SURMOUNT-1, read without the press release Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on…
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #23 · Compounds › Oral incretins · 22 Sep 2024 · 32 likes Building on post #22 rather than restating it. Orforglipron is a small molecule rather than a peptide, which changes almost everything about how it is made, stored and…
Why a preprint's supplementary material is often the best part Replied, post #15 · Evidence › Preprints · 7 Sep 2024 · 0 likes Where a preprint's numbers are the basis of a claim being repeated here, someone should check whether the published version exists yet. That check is nearly always…
The mass-error checker and its intended scope Replied, post #128 · Data & Tools › Calculators · 16 Jul 2024 · 0 likes I had written a reply contradicting post #124 and deleted it. Here is what survived. The parts-per-million mass-error calculation is simple enough to do mentally to one…